Middle East & Africa Blood Irradiation Market Forecast to 2028 - COVID-19 Impact and Regional Analysis

List of Tables

The blood irradiation market in the Middle East & Africa is expected to grow from US$ 1.62 million in 2022 to US$ 2.18 million by 2028. It is estimated to grow at a CAGR of 5.1% from 2022 to 2028.

Technological Advancements and Product Launches to Introduce New Trends in Market

Trends in the healthcare sector are changing drastically with continuous technological developments and innovations, contributing to the enhancement of the quality of healthcare services and care. Various blood irradiation market players are operating regionally and striving to expand their market shares, followed by the rising demand for blood irradiation. They are investing significantly in research and development activities to introduce novel blood irradiation devices and technologies. There have been advancements in alternative technologies such as proton and ion beam therapies that use high-energy, positive ions and have high precision in treating tumors with reduced exposure to normal tissues. Moreover, FLASH radiotherapy, carbon ion therapy, volumetric-modulated arc therapy, and intensity-modulated radiotherapy treat solid tumors. These technological advancements have a high precision rate with reduced side effects. Thus, an increase in technological advancements, product launches, and the increasing use of alternative technologies are expected to support the growth of the Middle East & Africa blood irradiation market in the coming years.

Market Overview

The Middle East & Africa blood irradiation market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. The market growth in this region is attributed to the increasing prevalence of communicable and noncommunicable diseases, growing number of research studies, an improvements in healthcare facilities. Additionally, Saudi Arabia is one of the important countries in the Middle Eastern region that has significant scope for the blood irradiation market. The healthcare system in the country is developing at rapid pace as well as increasing number of international companies are developing medical and research team in the country. A sharp increase in the state health budget is also expected to drive the growth of blood irradiation market in the country.

Middle East & Africa Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Blood Irradiation Market Segmentation

The Middle East & Africa blood irradiation market is segmented into type, indication, end user, and country.

Based on type, the market is segmented into intravenous laser blood irradiation, transcutaneous laser blood irradiation, and extracorporeal blood irradiation. The intravenous laser blood irradiation segment registered the largest market share in 2022.

Based on indication, the market is segmented into acute leukemia, lymphoma, solid tumors, pelvic tumors and others. The acute leukemia segment held the largest market share in 2022.

Based on end user, the market is segmented into hospitals, blood banks, diagnostics clinics, and research institutes. The hospital segment held the largest market share in 2022.

Based on country, the market is segmented into UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. Saudi Arabia dominated the market share in 2022.

Hitachi, Ltd.; Best Theratronics Ltd.; Gilardoni S.p.A.; Typenex Medical; and Actemium are the leading companies operating in the blood irradiation market in the Middle East & Africa.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Blood Irradiation Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa Blood Irradiation Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: BMIRE00027195

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Middle East & Africa Blood Irradiation Market - By Type
- 1.3.2 Middle East & Africa Blood Irradiation Market - By Indication
- 1.3.3 Middle East & Africa Blood Irradiation Market - By End User
- 1.3.4 Middle East & Africa Blood Irradiation Market - By Country

2. Middle East & Africa Blood Irradiation Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Middle East & Africa Blood Irradiation Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Middle East and Africa PEST Analysis
4.3 Experts Opinion

5. Middle East & Africa Blood Irradiation Market- Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increase in Communicable and Noncommunicable Diseases
- 5.1.2 Rise in Healthcare Expenditure and Government Initiatives
5.2 Market Restraints
- 5.2.1 Stringent Regulatory Policies, High Cost, and Challenges with Blood Component Irradiation
5.3 Market Opportunities
- 5.3.1 Increasing Immunocompromised Population and Rising Incidences of Leukemia and Lymphoma
5.4 Future Trends
- 5.4.1 Technological Advancements and Product Launches
5.5 Impact Analysis

6. Blood Irradiation Market- Middle East & Africa Analysis

6.1 Middle East & Africa Blood Irradiation Market Revenue Forecasts and Analysis
- 6.1.1 Overview
- 6.1.2 Middle East & Africa Blood Irradiation Market, and Forecast to 2028 (Units)

7. Middle East & Africa Blood Irradiation Market Analysis - By Type

7.1 Overview
7.2 Middle East & Africa Blood Irradiation Market Revenue Share, by Type (2021 and 2028)
- 7.2.1 Middle East & Africa: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
7.3 Intravenous Laser Blood Radiation
- 7.3.1 Overview
- 7.3.2 Middle East & Africa Intravenous Laser Blood Radiation: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Transcutaneous Laser Blood Radiation
- 7.4.1 Overview
- 7.4.2 Middle East & Africa Transcutaneous Laser Blood Radiation: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Extracorporeal Blood Radiation
- 7.5.1 Overview
- 7.5.2 Middle East & Africa Extracorporeal Blood Radiation: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)

8. Middle East & Africa Blood Irradiation Market - By End User

8.1 Overview
8.2 Middle East & Africa Blood Irradiation Market, by End User, 2021 and 2028 (%)
- 8.2.1 Middle East & Africa Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Middle East & Africa Hospitals: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Blood Banks
- 8.4.1 Overview
- 8.4.2 Middle East & Africa Blood Banks: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Diagnostic Centers
- 8.5.1 Overview
- 8.5.2 Middle East & Africa Diagnostic Centers: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Research Institutes
- 8.6.1 Overview
- 8.6.2 Middle East & Africa Research Institutes: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Blood Irradiation Market - By Indication

9.1 Overview
9.2 Middle East & Africa Blood Irradiation Market, by Indication, 2021 and 2028 (%)
- 9.2.1 Middle East & Africa Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
9.3 Acute Leukemia
- 9.3.1 Overview
- 9.3.2 Middle East & Africa Acute Leukemia: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Solid Tumors
- 9.4.1 Overview
- 9.4.2 Middle East & Africa Solid Tumors: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Pelvic Tumors
- 9.5.1 Overview
- 9.5.2 Middle East & Africa Pelvic Tumors: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Lymphoma
- 9.6.1 Overview
- 9.6.2 Middle East & Africa Lymphoma: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 Middle East & Africa Others: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)

10. Middle East & Africa Blood Irradiation Market - Country Analysis

10.1 Middle East & Africa Blood Irradiation Market Revenue and Forecasts To 2028
- 10.1.1 Overview
- 10.1.2 Middle East & Africa: Blood Irradiation Market, by Country, 2021 & 2028 (%)
  - 10.1.2.1 Saudi Arabia: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 Saudi Arabia: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.3 Saudi Arabia: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.1.4 Saudi Arabia Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.5 Saudi Arabia Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.2.2 UAE: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 UAE: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.3 UAE: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.2.4 UAE Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.5 UAE Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.2.3 South Africa: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 South Africa: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.3 South Africa: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.3.4 South Africa Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.5 South Africa Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.2.4 Rest of Middle East & Africa: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.4.1 Overview
    - 10.1.2.4.2 Rest of Middle East & Africa: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.4.3 Rest of Middle East & Africa: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.4.4 Rest of Middle East & Africa: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
    - 10.1.2.4.5 Rest of Middle East & Africa: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)

11. Middle East & Africa Blood Irradiation Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Middle East & Africa Blood Irradiation Market, 2021-2028
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Hitachi, Ltd.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Best Theratronics Ltd.,
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Gilardoni S.p.A.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Typenex Medical
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Actemium
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms